TrialJournal of translational medicine2018

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Linda M Liau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.